Knee News and Research

RSS

Siemens Healthcare launches innovative scanners at RSNA 2009

Siemens Healthcare redefines productivity with a new generation of its Tim® (Total imaging matrix) technology and with its new Dot(TM) (Day optimizing throughput) engine.

29 Nov 2009

Researchers find causes for patellofemoral pain syndrome

From professional athletes to weekend warriors, the condition known as "runner's knee" is a painful and potentially debilitating injury suffered by millions of people - although until now, it has been unclear just what causes it.

24 Nov 2009

"Cheetah" limbs gave Olympic hopeful a clear and major advantage over his competition

The artificial lower limbs of double-amputee Olympic hopeful Oscar Pistorius give him a clear and major advantage over his competition, taking 10 seconds or more off what his 400-meter race time would be if his prosthesis behaved like intact limbs.

20 Nov 2009

Cardiovascular Systems commences patient enrollment in CALCIUM 360° clinical trial

Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI’s Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg.

19 Nov 2009

Bullseye Anatomic Cruciate Reconstruction System released

CONMED Corporation's CONMED Linvatec arthroscopy unit today announced the release of the Bullseye™ Anatomic Cruciate Reconstruction System, a novel guide system for anatomic cruciate ligament (ACL and PCL) reconstructions of the knee.

16 Nov 2009

Cheerleading injuries in the U.S.: 60% occur due to stunts

Whether rallying the crowd at a sporting event or participating in competition, cheerleading can be both fun and physically demanding. Although integral to cheerleading routines, performing stunts can lead to injury. Stunt-related injuries accounted for more than half (60 percent) of U.S. cheerleading injuries from June 2006 through June 2007, according to a new study conducted by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital.

16 Nov 2009

PRP injections expedite the healing process in injured athletes

Injured athletes who have their own enriched plasma injected into their bodies are healing faster and spending less time on the bench or on the disabled list.

13 Nov 2009

Negative and positive emotions have a direct impact on pain, says new study

Getting a flu shot this fall? Canadians scientists have found that focusing on a pretty image could alleviate the sting of that vaccine. According to a new Universit- de Montr-al study, published in the latest edition of the Proceedings of the National Academy of Sciences (PNAS), negative and positive emotions have a direct impact on pain.

11 Nov 2009

Specialization in one sport increases the risk of injury, find researchers

Gifted young athletes are under increasing pressure to play only one sport year round.

9 Nov 2009

FDA approves the New Drug Application for Pennsaid Topical Solution

Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid(R) Topical Solution (diclofenac sodium topical solution) 1.5% w/w.

5 Nov 2009

Pennsaid Topical Solution approved by FDA

Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.

5 Nov 2009

MRG's new report on the European markets for small-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.

4 Nov 2009

ThromboGenics issues business update for the third-quarter of 2009

ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, is today issuing a business update for the period ending 30 September, 2009.

4 Nov 2009

Financial results for third-quarter 2009 announced by Combinatorx

CombinatoRx, Incorporated today reported financial results for the third quarter ended September 30, 2009.

3 Nov 2009

Risk of postoperative visual loss is highest after heart surgery

Imagine waking up after surgery to find out you have lost your sight—permanently. Although rare, postoperative visual loss is a well-recognized complication of anesthesia and surgery that is more common after certain types of procedures and in some groups of patients, according to a study in the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

3 Nov 2009

Appropriate treatment for children with meniscal tears leads to high success rate: Study

The meniscus is a rubber-like, crescent moon-shaped cartilage cushion that sits between the leg and thigh bone. Each knee has two menisci: one on the inside of the knee joint and one on the outside. In recent years, more children have been diagnosed with tears to this area (meniscal tears); however, according to a literature review published in the November 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), prospects for a full recovery are high.

3 Nov 2009

AcelRx Pharmaceuticals completes End-of-Phase 2 meeting with the FDA for its ARX-01drug/device

AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company's proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.

30 Oct 2009

Recruitment of Phase II trial of TB-402 completed ahead of schedule

ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.

28 Oct 2009

Report on healthcare procedure costs published

For the first time, Virginians have access to information on what health care procedures cost -- before they receive medical care. Virginia Health Information has published a report showing the average amounts that health insurers in Virginia pay for 31 procedures -- including preventive, emergency, outpatient, and hospital inpatient care.

27 Oct 2009

Hospital gives Medicare patients cash back for surgery

In a story done by Kaiser Health News in collaboration with USA Today, KHN staff writer Phil Galewitz reports on a hospital in Tulsa, Okla. "An hour into knee replacement surgery — with U2's I Still Haven't Found What I'm Looking For playing in the background — Dr. Yogesh Mittal smiles as he raises the left leg of his patient, 76-year-old Frank Morrow.

26 Oct 2009